Clinical trial

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

NCT00941382

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Sibutramine-Metformin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Sibutramine Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE3

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

Sibutramine-MetforminDRUG

SibutramineDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Laboratorios Silanes S.A. de C.V.lead sponsor

Mapped research locations

GuadalajaraJalisco, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00941382 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.